Integrase-Deficient Lentivirus: Opportunities and Challenges for Human Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|14|5|352-364

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.14, Iss.5, 2014-10, pp. : 352-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospects for the Therapeutic Application of Lentivirus-Based Gene Therapy to HIV-1 Infection

By  

Current Gene Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 1-8

Bentham Science Publishers

Access to resources Recommend Favorite

The &phis;C31 Integrase System for Gene Therapy

By  

Current Gene Therapy, Vol. 6, Iss. 6, 2006-12 ,pp. : 633-645

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy

By Ferraro Thomas N   Dlugos Dennis J   Buono Russell J  

Pharmacogenomics, Vol. 7, Iss. 1, 2006-01 ,pp. : 89-103

Future Medicine

Access to resources Recommend Favorite

Diabetes Gene Therapy: Potential and Challenges

By  

Current Gene Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 65-82

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes

By  

Current Gene Therapy, Vol. 17, Iss. 3, 2017-12 ,pp. : 235-247

Bentham Science Publishers

Access to resources Recommend Favorite